The effects of early and late bone marrow transplantation in siblings with alpha-mannosidosis. Is early haematopoietic cell transplantation the preferred treatment option?
This article documents both the neurological and physical outcomes of the first published set of siblings undergoing transplantation at differing ages for α-mannosidosis. The older brother, the index case, was diagnosed at the age of 3 years and underwent transplantation at 13 years for the treatment of increasing somatic problems and recurrent infections. The younger brother had undergone transplantation pre-symptomatically at 6 months of age. Their clinical, radiological and developmental outcomes are documented and compared with the previous published cases, with the case for early transplantation being weighted against other potential therapies.
Broomfield
A A
AA
Department of Genetic Medicine, Royal Manchester Children's Hospital, Manchester, UK. BroomA@gosh.nhs.uk
Chakrapani
A
A
Wraith
J E
JE
D000293:Adolescent; D041923:Adolescent Development; D002657:Child Development; D020022:Genetic Predisposition to Disease; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D040941:Heredity; D006801:Humans; D007223:Infant; D008297:Male; D018579:Patient Selection; D010375:Pedigree; D010641:Phenotype; D012307:Risk Factors; D035781:Siblings; D013997:Time Factors; D061665:Time-to-Treatment; D016896:Treatment Outcome; D008363:alpha-Mannosidosis / Q000150:complications / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology / Q000523:psychology / Q000601:surgery*